Trials / Completed
CompletedNCT04913116
Generic Testing of Antigen Tests for COVID-19 in Denmark
Agreement of Antigen Tests on Oral Pharyngeal Swabs or Less Invasive Testing With PCR, for Detecting SARS-CoV-2 in Adults: A Prospective Nationwide Observational Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 4,000 (actual)
- Sponsor
- Hvidovre University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the analytical and clinical sensitivity and specificity of antigen tests performed as oropharyngeal swabs, outer nasal swabs, saliva swabs or breath tests including self-tests for SARS-CoV-2 towards standard RT-PCR testing. For each test 200 SARS-CoV-2 positive and 200 SARS-CoV-2 negative individuals previously defined by RT-PCR are tested. When tested an additional RT-PCR test is performed to verify status. Analytical sensitivity and specificity is determined on 210 SARS-CoV-2 positive samples with known Cq and 100 SARS-CoV-2 negative samples. 30 companies with a total of 55 tests participate in this nationwide study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Comparison of antigen tests with RT-PCR as reference method | Antigen tests are performed locally including sampling from multiple anatomical testing sites. A reference oropharyngeal swab is always send for RT-PCR for SARS-CoV-2 at DTU to verify the status of the patient. RT-PCR samples from other anatomical test locations may be included. |
Timeline
- Start date
- 2021-01-18
- Primary completion
- 2021-09-09
- Completion
- 2021-09-09
- First posted
- 2021-06-04
- Last updated
- 2022-01-26
Locations
3 sites across 1 country: Denmark
Source: ClinicalTrials.gov record NCT04913116. Inclusion in this directory is not an endorsement.